ImpediMed Limited is a medical software technology company that specializes in the development, manufacturing, and selling of bioimpedance spectroscopy (BIS) devices and software services. With a presence in Australia, North America, and globally, the company offers SOZO, a noninvasive BIS device for assessing lymphedema and monitoring fluid status in heart failure patients. Additionally, ImpediMed provides SFB7, a single-channel, tetrapolar BIS device that analyzes body composition in healthy individuals, and ImpediVET, a veterinary application for measuring fluid status and tissue composition. The company's clientele comprises hospitals and clinics worldwide. ImpediMed Limited was established in 1999 and is headquartered in Pinkenba, Australia.
ImpediMed Limited's ticker is IPD
The company's shares trade on the ASX stock exchange
They are based in Pinkenba, Australia
There are 51-200 employees working at ImpediMed Limited
It is https://www.impedimed.com/
ImpediMed Limited is in the Healthcare sector
ImpediMed Limited is in the Medical Appliances & Equipment industry
The following five companies are ImpediMed Limited's industry peers: